SecBot SecBot
PRESS-RELEASE ·Filed Aug 11, 2026

VTAK

Catheter Precision, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago WireGlobeNewswire
Press release · Contract
Actionable Insight • Neutral

This is a routine marketing partnership with no disclosed financial terms. Monitor for any subsequent material agreements or revenue guidance from Flyte, but this event alone does not warrant a trading decision.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
VTAK ▼ -38.97% at T+20d
NEUTRAL call -38.97% · α vs SPY -37.91% · entry $0.2900 → $0.1770
Next anchor: T+60d in 8d
Entry = T+0 close
Aug 11, 2026
via day close
T+1d
+1.03%
call +1.03% · α +0.78%
$0.2930
settled 3mo ago
T+5d
-23.14%
call -23.14% · α -22.73%
$0.2229
settled 2mo ago
T+20d
-38.97%
call -38.97% · α -37.91%
$0.1770
settled 7w ago
T+60d
Pending
in 8d

Price Chart

Loading chart...

Executive Summary

Catheter Precision subsidiary Flyte announced a strategic partnership with The Nucleus Network to sponsor its inaugural event on August 15, 2026. This is a marketing/community-building initiative with no disclosed financial terms, deal value, or revenue impact. For a micro-cap company ($1M market cap), such non-material partnership announcements are routine and unlikely to move the stock.

Key Facts

  • Flyte, a subsidiary of Catheter Precision (VTAK), is an official partner of The Nucleus Network's inaugural event on August 15, 2026.
  • The event targets ~200 founders, investors, and operators for networking and brand activations.
  • No financial terms, revenue projections, or material obligations were disclosed in the press release.
  • Flyte operates a fleet of Cirrus Vision Jets for short-haul private aviation, but this partnership does not involve aircraft sales or operational expansion.

Financial Impact

No financial terms disclosed; immaterial for a $1M market cap company

Risk Factors

  • Partnership may not generate measurable revenue or customer acquisition for Flyte
  • Micro-cap volatility could amplify any reaction to non-material news
  • No disclosed financial commitment from either party reduces credibility of impact

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3342686
23 reports for VTAK
Performance horizon
67% Hit rate @ T+5 4 of 6 directional calls Went positive at some point 6 of 6 best @ T+60▲ +82.93%Jun 22, 2026
Filters
Rows
Reports for VTAK — sortable, filterable
TypeNow
Oct 9, 2026
17d ago
8-K
BEARISH ★ 7/10
$1.00 $0.8200▲ +18.00%▲ +16.51%$0.6500 (+35.00%)
Oct 5, 2026
21d ago
Press Release
NEUTRAL ★ 2/10
$1.62 $1.00▼ −38.27%▼ −38.69%$0.6500 (−59.88%)
Oct 2, 2026
24d ago
8-K
NEUTRAL ★ 5/10
$1.62 $1.00▼ −38.27%▼ −38.69%$0.6500 (−59.88%)
Oct 2, 2026
24d ago
Press Release
NEUTRAL ★ 4/10
$1.62 $1.00▼ −38.27%▼ −38.69%$0.6500 (−59.88%)
Sep 28, 2026
28d ago
Press Release
NEUTRAL ★ 2/10
$0.1467awaiting T+5—$0.6500 (+343.08%)
Sep 25, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$0.1467awaiting T+5—$0.6500 (+343.08%)
Aug 27, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$0.2027 $0.1966▼ −3.01%▼ −3.28%$0.6500 (+220.67%)
Aug 11, 2026
10w ago
Press Release
NEUTRAL ★ 2/10
$0.2900 $0.2229▼ −23.14%▼ −22.73%$0.6500 (+124.14%)
Aug 4, 2026
11w ago
Press Release
NEUTRAL ★ 3/10
$0.2760 $0.2930▲ +6.16%▲ +6.26%$0.6500 (+135.51%)
Jul 13, 2026
15w ago
EFFECT
BEARISH ★ 7/10
$0.6504 $0.5020▲ +22.82%▲ +21.87%$0.6500 (+0.06%)
Showing 10 of 23

US Market Status

Market Closed — Opens in 7h 32m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 11, 2026